Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alfredo Papa and Antonio Tursi.
Alfredo Papa
Connection Strength
6.294
Antonio Tursi
  1. Impact of Anti-TNFa Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases. J Crohns Colitis. 2020 Nov 07; 14(11):1646-1647.
    View in: PubMed
    Score: 0.912
  2. Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase. Therap Adv Gastroenterol. 2020; 13:1756284820968747.
    View in: PubMed
    Score: 0.910
  3. Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2020 10; 115(10):1722-1724.
    View in: PubMed
    Score: 0.906
  4. INTESTINAL MICROBIOME MODULATION DURING COVID-19: ANOTHER CHANCE TO MANAGE THE DISEASE? Gastroenterology. 2020 Sep 15.
    View in: PubMed
    Score: 0.903
  5. Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape. Clin Gastroenterol Hepatol. 2021 01; 19(1):205-206.
    View in: PubMed
    Score: 0.898
  6. Anti-TNF-a Agents in Inflammatory Bowel Disease and Course of COVID-19. Inflamm Bowel Dis. 2020 06 18; 26(7):e73.
    View in: PubMed
    Score: 0.888
  7. COVID-19 infection in Crohn's disease under treatment with adalimumab. Gut. 2020 07; 69(7):1364-1365.
    View in: PubMed
    Score: 0.878
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.